Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

CAPS Rating: 4 out of 5

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

Caps

How do you think RIGL will perform against the market?

Add Stock to CAPS Watchlist

All Players

153 Outperform
57 Underperform
 

All-Star Players

36 Outperform
15 Underperform
 

Wall Street

5 Outperform
1 Underperform
 

Top RIGL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFang4apples (65.19)
Submitted February 19, 2017

I think the FDA will accept combined data for fostamatinib in ITP. The company probably should have aimed for a different primary endpoint, but overall it looks like a good drug with a solid future in an orphan population with unmet need.

ScreenerStizBear (44.95)
Submitted June 26, 2008

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

RIGL VS S&P 500 (SPY)

Fools bullish on RIGL are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about RIGL.

Recs

1
Member Avatar TMFang4apples (65.19) Submitted: 2/19/2017 3:57:15 PM : Outperform Start Price: $2.40 RIGL Score: +13.44

I think the FDA will accept combined data for fostamatinib in ITP. The company probably should have aimed for a different primary endpoint, but overall it looks like a good drug with a solid future in an orphan population with unmet need.

Recs

0
Member Avatar PrototypeZ (31.99) Submitted: 1/6/2016 11:34:16 AM : Outperform Start Price: $6.67 RIGL Score: -118.81

Pharma lemming pick zz

Recs

0
Member Avatar bIlluminati (29.91) Submitted: 11/7/2014 3:04:27 PM : Underperform Start Price: $1.80 RIGL Score: -35.87

No profits.

Leaderboard

Find the members with the highest scoring picks in RIGL.

Score Leader

qubit15

qubit15 (< 20) Score: +263.49

The Score Leader is the player with the highest score across all their picks in RIGL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
qubit15 < 20 1/21/2009 Underperform NS $6.95 -59.71% +203.78% +263.49 0 Comment
cybob2000 43.25 10/23/2008 Underperform 3W $15.64 -82.10% +176.27% +258.36 0 Comment
schwah8 98.42 10/13/2008 Underperform NS $18.26 -84.67% +164.03% +248.70 0 Comment
robo2011 33.15 11/17/2008 Underperform NS $6.53 -57.12% +188.76% +245.88 0 Comment
anticitradeshort 29.60 4/20/2009 Underperform NS $6.43 -56.45% +187.19% +243.64 0 Comment
EV38biotech 38.42 11/5/2008 Underperform 5Y $8.60 -67.44% +153.49% +220.93 0 Comment
Mynx828 85.56 9/17/2009 Underperform 5Y $7.45 -62.42% +127.95% +190.36 0 Comment
darksider389 84.06 7/7/2008 Underperform 3M $21.97 -87.26% +101.49% +188.75 0 Comment
longtermgrowth09 < 20 12/17/2009 Underperform 5Y $8.97 -68.78% +119.59% +188.37 0 Comment
flats66 65.92 8/14/2008 9/18/2009 Underperform 3Y $22.71 -87.67% +96.18% +183.85 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRothCapital 70.83 9/6/2012 Outperform NS $10.20 -72.55% +71.51% -144.06 0 Comment
TrackJimCramer 84.49 12/1/2011 Underperform 3W $7.52 -62.77% +94.55% +157.32 0 Comment
TrackJGreenblatt 68.63 4/25/2011 Outperform 1Y $7.82 +1.41% +3.96% -2.56 4/25/2012 @ $7.93 1 Comment
TrackPiperJaff 86.65 3/12/2010 Outperform NS $8.01 -55.56% +42.16% -97.72 6/4/2013 @ $3.56 0 Comment
TrackRBCCapMkts 87.95 11/24/2009 Outperform NS $8.16 -1.35% -4.38% +3.03 8/24/2010 @ $8.05 0 Comment
TrackRodmanRen < 20 6/9/2009 Outperform NS $10.07 -72.19% +160.08% -232.28 0 Comment
TrackRBCCapMkts 87.95 1/30/2009 Underperform NS $6.80 +20.00% +30.95% +10.95 11/23/2009 @ $8.16 0 Comment
TrackOppenheimer 72.00 12/1/2008 Outperform NS $7.22 -61.22% +185.05% -246.27 0 Comment
TrackRBCCapMkts 87.95 9/3/2008 Outperform NS $23.35 -62.87% -31.71% -31.16 10/28/2008 @ $8.67 0 Comment
TrackCitigroup 94.19 8/27/2008 Outperform NS $22.40 -58.21% -23.67% -34.55 7/24/2009 @ $9.36 0 Comment
TrackStanfordRes < 20 7/22/2008 Outperform NS $24.58 -68.71% +10.24% -78.96 4/17/2012 @ $7.69 0 Comment
TrackFortisBank < 20 1/7/2008 Outperform NS $24.19 -9.01% -24.30% +15.29 10/2/2008 @ $22.01 0 Comment
TrackLehmanBros < 20 12/14/2007 Outperform NS $27.33 -71.86% -6.73% -65.13 4/17/2012 @ $7.69 0 Comment
TrackCreditSuiss 91.35 7/19/2007 Outperform NS $8.76 -68.04% +64.91% -132.94 0 Comment
TrackJefferies 86.50 6/8/2007 Outperform NS $9.50 -70.53% +71.93% -142.45 0 Comment

Featured Broker Partners